PLSE
PULSE BIOSCIENCES, INC.Company Information
- Company Name
- PULSE BIOSCIENCES, INC.
- CIK
- CIK0001625101
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- PLSE: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- PLSE
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-09-01
- Last sale
- 2026-02-18
- Shares purchased (TTM)
- 711,927
- Shares sold (TTM)
- 95,000
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 10,089,287
- Shares outstanding
- 69,200,020
- Ownership
- 14.58%
Earnings Market Reaction
- Filing date
- 2026-08-06
- Price on filing date
- —
- 1-month reaction
- 24.40%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents At Carrying Value | 102 | 68 | 81 | 95 | 106 | 119 | 118 | 79 | 26 | 35 | 44 | 50 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 106 | 71 | 83 | 97 | 108 | 121 | 119 | 80 | 27 | 36 | 45 | 52 | ||||||
| Accounts Receivable Net Current | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | ||||||
| Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | 4 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Property Plant And Equipment Net | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | ||||||
| Finite Lived Intangible Assets Net | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | ||||||
| Goodwill | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | ||||||
| Operating Lease Right Of Use Asset | 5 | 6 | 6 | 6 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | ||||||
| Other Assets Noncurrent | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | ||||||
| Assets | 116 | 82 | 95 | 109 | 120 | 133 | 132 | 93 | 40 | 49 | 59 | 66 | ||||||
| Accounts Payable Current | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | ||||||
| Accrued Liabilities Current | 6 | 5 | 4 | 5 | 5 | 4 | 7 | 4 | 3 | 2 | 4 | 3 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 11 | 10 | 8 | 10 | 9 | 8 | 10 | 7 | 6 | 5 | 7 | 5 | ||||||
| Operating Lease Liability Current | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Notes Payable Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | 5 | 6 | 6 | 6 | 7 | 7 | 8 | 7 | 7 | 8 | 8 | 8 | ||||||
| Liabilities | 16 | 15 | 14 | 16 | 16 | 15 | 18 | 14 | 13 | 13 | 15 | 14 | ||||||
| Long Term Notes Payable | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | 100 | 66 | 81 | 93 | 104 | 118 | 115 | 79 | 27 | 36 | 44 | 52 | ||||||
| Additional Paid In Capital Common Stock | 606 | 548 | 544 | 538 | 531 | 526 | 505 | 450 | 385 | 383 | 381 | 377 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Retained Earnings Accumulated Deficit | -507 | -482 | -463 | -446 | -426 | -407 | -391 | -371 | -358 | -347 | -337 | -325 | ||||||
| Liabilities And Stockholders Equity | 116 | 82 | 95 | 109 | 120 | 133 | 132 | 93 | 40 | 49 | 59 | 66 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | ||||||
| Common Stock Shares Issued | 71 | 68 | 68 | 68 | 67 | 67 | 66 | 62 | 55 | 55 | 55 | 55 | ||||||
| Shares Outstanding | 71 | 68 | 68 | 68 | 67 | 67 | 66 | 62 | 55 | 55 | 55 | 55 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialPULSE BIOSCIENCES, INC. (PLSE) — SEC Financial Statements & Analysis
PULSE BIOSCIENCES, INC. (PLSE) is a surgical & medical instruments & apparatus company, incorporated in DE. PULSE BIOSCIENCES, INC. trades on Nasdaq as: PLSE. PULSE BIOSCIENCES, INC. (PLSE)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, PULSE BIOSCIENCES, INC. carries a market cap of $1.92B, a P/E ratio of -23.97x, a P/B ratio of 19.29x, a P/S ratio of 1619.34x, an enterprise value of $1.82B, and an EV/EBITDA multiple of -21.98x. On profitability, it posts a gross margin of 0.25%, an operating margin of -7007.76%, a net margin of -6755.78%, a Return on Equity (ROE) of -78.49%, a Return on Assets (ROA) of -67.90%, and a Return on Invested Capital (ROIC) of -5227.11%. Per share, it reports EPS of $-1.16, free cash flow per share of $-0.89, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of 17.68% year-over-year, and EPS growth of 14.41% year-over-year. On the balance sheet, it maintains a current ratio of 9.63x, a quick ratio of 9.27x, working capital of $94.72M, a debt-to-equity ratio of 0.16x, a debt ratio of 0.14, an interest coverage ratio of -27.51x, free cash flow of $-61.39M (TTM), and net debt of $-101.62M. Figures sourced from SEC EDGAR.
- Market Cap
- $1.92B
- P/E TTM
- -23.97x
- EPS TTM
- $-1.16
- P/B TTM
- 19.29x
- ROE TTM
- -78.49%
- ROA TTM
- -67.90%
- Debt To Equity
- 0.16x
- Free Cash Flow TTM
- $-61.39M
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is PULSE BIOSCIENCES, INC. in?
PULSE BIOSCIENCES, INC. (PLSE) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does PLSE trade on?
PULSE BIOSCIENCES, INC. (PLSE) trades on the Nasdaq.
Where is PULSE BIOSCIENCES, INC. incorporated?
PULSE BIOSCIENCES, INC. is incorporated in DE.
When was PULSE BIOSCIENCES, INC. (PLSE)'s most recent SEC filing?
PULSE BIOSCIENCES, INC. (PLSE)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06.
What is PLSE's market cap?
PULSE BIOSCIENCES, INC. (PLSE) has a market capitalization of $1.92B as of 2026-06-30.
What is PLSE's EPS (earnings per share)?
PULSE BIOSCIENCES, INC. (PLSE)'s trailing twelve month EPS is $-1.16 as of 2026-06-30.
What is PLSE's ROE (return on equity)?
PULSE BIOSCIENCES, INC. (PLSE)'s trailing twelve month Return on Equity (ROE) is -78.49% as of 2026-06-30.
What is PLSE's ROA (return on assets)?
PULSE BIOSCIENCES, INC. (PLSE)'s trailing twelve month Return on Assets (ROA) is -67.90% as of 2026-06-30.
What is PLSE's ROIC (return on invested capital)?
PULSE BIOSCIENCES, INC. (PLSE)'s trailing twelve month Return on Invested Capital (ROIC) is -5227.11% as of 2024-09-30.
What is PLSE's EV/EBITDA?
PULSE BIOSCIENCES, INC. (PLSE)'s trailing twelve month EV/EBITDA is -21.98x as of 2026-06-30.